Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Raymond James Financial, Inc. (RJF) Price & Performance

Cronos Group IncTrade
Raymond James Financial, Inc.Trade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Raymond James Financial, Inc. — how do they compare? Cronos Group Inc trades at $3.14 (market cap $1.14B), while Raymond James Financial, Inc. trades at $180.86 (market cap $34.63B). The key difference: Raymond James Financial, Inc. is far larger — about 30.4× Cronos Group Inc's market cap, and Raymond James Financial, Inc. pays a 1.2% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.

CRONRJF
Market Cap
$1.14B$34.63B
Sector
HealthFinancials
52-Week High
$3.27$180.55
52-Week Low
$2.30$140.89
Enterprise Value
$341.13M
Dividend Yield
1.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

Cronos Group (CRON) trades at $3.125, up 4.17% today. The stock shows a bullish technical signal with strong moving average support. Recent Q2 2026 earnings beat expectations with $0.09 EPS versus $0.01 expected, driven by 58% YoY revenue growth. However, the company posted a net loss of $9.45M in 2025, though margins are improving from prior years.

Outlook is mixed; strong international expansion and product launches support growth, but negative cash flow and intense competition pose risks. Analyst consensus is cautious with 60% hold ratings. The stock offers growth potential but requires monitoring of profitability and cash management.

Raymond James Financial, Inc.

Raymond James Financial (RJF) trades at $180.34, up 0.7% for the day, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust revenue growth, with 2025 revenue at $13.84B and net income of $2.14B, supported by a P/E of 15.69 and net margin of 15.37%. Recent news highlights record Q3 2026 results and a golden cross formation, indicating positive momentum.

Outlook is positive due to consistent earnings outperformance and analyst buy ratings, but risks include volatile cash flows from investing activities and reliance on capital markets strength. The consensus price target of $183.75 suggests modest upside, with institutional interest shown by CalPERS' recent share acquisition.

Returns comparison

Trailing returns across standard periods

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About Raymond James Financial, Inc.

Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.

Read more on RJF